Company: AIP
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001193125-25-091349
Chunk: 39

Company: Arteris, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 39
---
 September 1, 2022, 2023 and 2024, respectively, and 
 the remaining 65,206 RSUs vest on September 1, 2025.                                                         |

| (6) | 84,247, 62,500, 62,500 and 40,753 RSUs vest on September 1 of 2022, 2023, 2024 and 2025, respectively. |

| (7) | The stock options vested as to 25% of the shares subject to the option on November 11, 2020 and as to 1/48th of 
 the shares subject to the option on each monthly anniversary thereafter.                                        |

Executive Compensation Arrangements NEO Employment Agreements We entered into an offer letter with each NEO other than Mr. Janac. Each such offer letter sets forth the terms of the named executive officer’s employment with us, including base salary, initial equity award grant and benefit entitlements. We have also entered into a change in control and severance agreement with each of our named executive officers, each of which was renewed in July 2024 for a three-year term. Under these agreements, if the applicable named executive officer’s employment with us is terminated without “cause” or the applicable named executive officer resigns for “good reason” (as each is defined in the applicable severance agreement), the named executive officer will be entitled to receive: (i) 12 months for Mr. Janac, nine months for Mr. Hawkins and six months for Mr. Moll of continued payment of base salary and (ii) payment or reimbursement of the cost of continued healthcare coverage for 12 months for Mr. Janac, nine months for Mr. Hawkins and six months for Mr. Moll. In lieu of the foregoing benefits, if the applicable named executive officer’s employment with us is terminated without “cause” or such NEO resigns for “good reason” during the period commencing on three months prior to a Change in Control (as defined in the 2021 Plan) and ending on the 12-monthanniversary following such Change in Control, the applicable named executive officer will be entitled to receive: (i) 18 months for Mr. Janac and 12 months for Messrs. Moll and Hawkins of continued payment of base salary, (ii) a pro-ratedportion of his target annual bonus, (iii) payment or reimbursement of the cost of continued healthcare coverage for 18 months for Mr. Janac and